How to find the Ariadne's thread in the labyrinth of salvage treatment options for metastatic colorectal cancer?
- PMID: 24673103
- DOI: 10.1517/14712598.2014.902926
How to find the Ariadne's thread in the labyrinth of salvage treatment options for metastatic colorectal cancer?
Abstract
Since a chance for cure was found out in metastatic colorectal cancer (mCRC) patients undergoing a resection of liver and lung metastases, high tumor shrinkage by chemotherapy regimens and their combination with targeted agents have been addressed in potentially resectable mCRC. However, most mCRC patients cannot reach this opportunity because of tumor burden or metastatic sites. For these patients a salvage systemic therapy could be offered to prolong survival. To date, a huge number of clinical trials provided some evidences for the achievement of this goal. A lot of chemotherapeutic regimens in combination with biological therapies are now available. We tried to propose a simple way to choose the best options and to plan an optimal sequence of treatments. This tool could help the oncologists worldwide to better and easily manage mCRC patients who need salvage systemic therapy.
Keywords: algorithm; chemotherapy; metastatic colorectal cancer; salvage treatment; target therapy.
Similar articles
-
Colorectal cancer metastases: surgical indications and multimodal approach.Hepatogastroenterology. 2003 Nov-Dec;50(54):1836-46. Hepatogastroenterology. 2003. PMID: 14696416
-
Role of adjuvant therapy after resection of colorectal cancer liver metastases.J Clin Oncol. 2010 May 1;28(13):2300-9. doi: 10.1200/JCO.2009.26.9340. Epub 2010 Apr 5. J Clin Oncol. 2010. PMID: 20368552 Review.
-
Surgical therapies in metastatic colorectal cancer with a potential for cure.Am J Clin Oncol. 2011 Jun;34(3):326-31. doi: 10.1097/COC.0b013e3181dbb9ad. Am J Clin Oncol. 2011. PMID: 20498587 Review.
-
Colorectal cancer with liver metastases -- is there a chance for cure?Chirurgia (Bucur). 2014 Mar-Apr;109(2):161-7. Chirurgia (Bucur). 2014. PMID: 24742404
-
[Therapy for advanced colorectal carcinoma--new developments and standards].Praxis (Bern 1994). 2005 Dec 7;94(49):1949-55. doi: 10.1024/0369-8394.94.49.1949. Praxis (Bern 1994). 2005. PMID: 16416928 Review. German.
Cited by
-
Immunohistochemical investigation of prognostic biomarkers in resected colorectal liver metastases: a systematic review and meta-analysis.Cancer Cell Int. 2018 Dec 27;18:217. doi: 10.1186/s12935-018-0715-8. eCollection 2018. Cancer Cell Int. 2018. PMID: 30602942 Free PMC article. Review.
-
Programmed death-ligand 1 expression in the tumour stroma of colorectal liver oligometastases and its association with prognosis after liver resection.Gastroenterol Rep (Oxf). 2020 Dec 10;9(5):443-450. doi: 10.1093/gastro/goaa077. eCollection 2021 Oct. Gastroenterol Rep (Oxf). 2020. PMID: 34733530 Free PMC article.
-
New findings on primary and acquired resistance to anti-EGFR therapy in metastatic colorectal cancer: do all roads lead to RAS?Oncotarget. 2015 Sep 22;6(28):24780-96. doi: 10.18632/oncotarget.4959. Oncotarget. 2015. PMID: 26318427 Free PMC article. Review.
-
What links BRAF to the heart function? New insights from the cardiotoxicity of BRAF inhibitors in cancer treatment.Oncotarget. 2015 Nov 3;6(34):35589-601. doi: 10.18632/oncotarget.5853. Oncotarget. 2015. PMID: 26431495 Free PMC article. Review.
-
State of the art in anti-cancer mAbs.J Biomed Sci. 2017 Feb 20;24(1):15. doi: 10.1186/s12929-016-0311-y. J Biomed Sci. 2017. PMID: 28219375 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical